DK0820308T3 - Konjugat til behandling af inflammatoriske sygdomme - Google Patents

Konjugat til behandling af inflammatoriske sygdomme

Info

Publication number
DK0820308T3
DK0820308T3 DK96909041T DK96909041T DK0820308T3 DK 0820308 T3 DK0820308 T3 DK 0820308T3 DK 96909041 T DK96909041 T DK 96909041T DK 96909041 T DK96909041 T DK 96909041T DK 0820308 T3 DK0820308 T3 DK 0820308T3
Authority
DK
Denmark
Prior art keywords
conjugate
treatment
inflammatory diseases
infectious
recognized
Prior art date
Application number
DK96909041T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Maier-Borst
Gerd Stehle
Hannsjoerg Sinn
Hans-Herrmann Schrenk
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of DK0820308T3 publication Critical patent/DK0820308T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK96909041T 1995-04-13 1996-04-12 Konjugat til behandling af inflammatoriske sygdomme DK0820308T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19514088A DE19514088A1 (de) 1995-04-13 1995-04-13 Konjugat zur Behandlung von Entzünduns-, Infektions- und/oder Hauterkrankungen
PCT/DE1996/000644 WO1996032133A2 (de) 1995-04-13 1996-04-12 Konjugat zur behandlung von entzündungs-, infektions- und/oder hauterkrankungen

Publications (1)

Publication Number Publication Date
DK0820308T3 true DK0820308T3 (da) 2001-11-12

Family

ID=7759679

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96909041T DK0820308T3 (da) 1995-04-13 1996-04-12 Konjugat til behandling af inflammatoriske sygdomme

Country Status (8)

Country Link
US (1) US6706713B1 (es)
EP (1) EP0820308B1 (es)
JP (1) JPH11503433A (es)
AT (1) ATE203680T1 (es)
DE (2) DE19514088A1 (es)
DK (1) DK0820308T3 (es)
ES (1) ES2162040T3 (es)
WO (1) WO1996032133A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19847362A1 (de) * 1998-10-14 2000-04-20 Deutsches Krebsforsch Makromolekulare Wirkstoffkonjugate und Verfahren zu ihrer Herstellung
EP1661584A1 (en) * 2004-11-26 2006-05-31 Heinz Dr. Faulstich Use of conjugates of amatoxins and phallotoxins with macromolecules for cancer and inflammation therapy
ATE521366T1 (de) * 2006-05-27 2011-09-15 Faulstich Heinz Dr Anwendung von amatoxin-konjugaten und phallotoxin-konjugaten mit makromolekülen zur krebstherapie und therapie von entzündungen
DE102017204850A1 (de) 2017-03-22 2018-09-27 Michael Denck HSA-Konjugat

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767745A (en) * 1982-04-20 1988-08-30 Merck Frosst Canada, Inc. Conjugates of leukotrienes with proteins
EP0179959A1 (en) * 1982-04-20 1986-05-07 Merck Frosst Canada Inc. Conjugates of leukotrienes with proteins
WO1987004351A1 (en) 1986-01-16 1987-07-30 The General Hospital Corporation Method for the diagnosis and treatment of inflammation
US4926869A (en) * 1986-01-16 1990-05-22 The General Hospital Corporation Method for the diagnosis and treatment of inflammation
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5051406A (en) * 1987-03-04 1991-09-24 Nippon Hypox Laboratories Incorporated Pharmaceutical composition using albumin as a carrier and process for producing the same
EP0282057A3 (en) 1987-03-11 1990-03-07 The Board Of Regents Of The University Of Michigan Chemo-radio-immuno-conjugates
JPS63267734A (ja) 1987-04-25 1988-11-04 Hiroshi Maeda 腫瘍および炎症用診断薬
US5208020A (en) * 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
IT8922275A0 (it) * 1990-10-25 1989-11-06 Baldacci Lab Spa Nuovi derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
AU663106B2 (en) 1991-08-02 1995-09-28 Meiji Milk Products Co., Ltd. Porphyrin-based anti-HIV drug
JPH07506830A (ja) 1992-05-15 1995-07-27 マリンクロット・メディカル・インコーポレイテッド 炎症検出用診断剤の製造法
TW381022B (en) * 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
DE69416078T2 (de) 1993-10-22 1999-05-27 Nihon Mediphysics Co Ltd Peptide mit Affinität für Entzündungen und deren radiomarkierte, diagnostische Zusammensetzungen
WO1995012414A1 (en) 1993-11-05 1995-05-11 Repligen Corporation Novel modified pf4 compositions and methods of use

Also Published As

Publication number Publication date
ATE203680T1 (de) 2001-08-15
WO1996032133A2 (de) 1996-10-17
DE59607417D1 (de) 2001-09-06
EP0820308B1 (de) 2001-08-01
EP0820308A2 (de) 1998-01-28
DE19514088A1 (de) 1996-10-17
ES2162040T3 (es) 2001-12-16
US6706713B1 (en) 2004-03-16
JPH11503433A (ja) 1999-03-26
WO1996032133A3 (de) 1997-02-13

Similar Documents

Publication Publication Date Title
DE69822665D1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
PT801564E (pt) Utilizacao de nebivolol como agente anti-aterogernico
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
UY23909A1 (es) Procedimiento para la preparacion de 6- derivados sustitutivos del acido micofenolico
DE69943107D1 (de) Behandlung von autoimmunerkrankungen
ES2110414T3 (es) Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion.
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
ATE234636T1 (de) Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether
TR200100637T2 (tr) Yeni doğal ürün türevleri
ES2180750T3 (es) Conjugado de un principio activo, un polieter y, en caso dado, una proteina nativa no considerada como exogena.
ATE198990T1 (de) Konjugat zur behandlung von entzündlichen erkrankungen
DK0820308T3 (da) Konjugat til behandling af inflammatoriske sygdomme
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
EA199800589A1 (ru) Применение экстрактов гинкго двудольного для получения фармацевтичиских композиций и способ косметической обработки с его использованием
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
CO4340732A1 (es) 4-amino-derivados del acido micofenolico 5-substituido
HUP9903892A2 (hu) Hidroxámsavszármazékok
EA200400535A1 (ru) ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
TR200003352T2 (tr) Yeni pentaerythrit türevleri, bunların imalatı ve kullanımları ile bunların sentezi için ara maddeler
DE69808839T2 (de) Makrophagen-stimulierende Protein für Behandlung von Erkrankungen des Nervensystems